Arriving in the landscape of weight management management, retatrutide is a unique approach. Beyond many current medications, retatrutide functions as a double agonist, concurrently targeting both GLP-like peptide-1 (GLP-1) and glucose-responsive insulinotropic hormone (GIP) sensors. The dual engagement encourages multiple beneficial effects, such